MicroRNAs in vascular biology - metabolism and atherosclerosis

Thrombosis and Haemostasis

Volumn 107, Issue 4, 2012, Pages 603-604

  Schober, Andreas ^a   Thum, Thomas ^b   Zernecke, Alma ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MICRORNA;

3' UNTRANSLATED REGION; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; EDITORIAL; GENE EXPRESSION; HUMAN; LEUKOCYTE; LIPID METABOLISM; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; RNA STABILITY; SMOOTH MUSCLE FIBER;

ANIMALS; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MICRORNAS; RIBONUCLEASE III;

EID: 84859340717     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th12-02-0122     Document Type: Editorial

References (18)

1. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-114.
2. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
4. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403: 901-906.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and function. Thromb Haemost 2012; 107: 605-610.
7. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008; 8: 802-815.
8. Manthey H, Zernecke A. Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb Haemost 2011; 106: 772-778.
9. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17:1410-1422.
10. Nazari-Jahantigh M, Wei Y, Schober A. The role of microRNAs in arterial remodelling. Thromb Haemost 2012; 107: 611-618.
11. Zernecke A. MicroRNAs in the regulation of immune cell functions - implications for atherosclerotic vascular disease. Thromb Haemost 2012; 107: 626-633.
12. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, Koeppel T. A, Zernecke A, Weber C. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012; 107: 619-625.
13. Stratz C, Nührenberg TG, Binder H, et al. Microarray profiling exhibits remarkable intra-individual stability of human platelet micro-RNA Thromb Haemost. 2012; 107: 634-641.
14. Weber C, Schober A, Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets 2010; 11: 950-956.
15. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336-342.
16. Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588.
17. Rayner KJ, Fernandez-Hernando C, Moore KJ. MicroRNAs regulating lipid metabolism in atherogenesis. Thromb Haemost 2012; 107: 642-647.
18. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.